You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
Consider obsoleting 'GO:0034627 de novo' NAD biosynthetic process (1 direct EXP) as an unnecessary grouping term
(Rossana: Probably this comes from the literature where de novo' NAD synthesis is used to group the Asp and Trp.)
Consider obsoleting 'GO:0034356 NAD biosynthesis via nicotinamide riboside salvage pathway' (7 direct EXP), since it's a single child of its parent term (we don't have separate terms for the other specific salvage pathways)
Consider obsoleting 'GO:1905012 regulation of 'de novo' NAD biosynthetic process from L-tryptophan' and it's two children (only 2 TAS annotations to the parent, none to the children), and other terms in this branch don't have regulation terms)
The text was updated successfully, but these errors were encountered:
Annotation review template:
https://docs.google.com/spreadsheets/d/13oNsCNrIDGH26TAKCvpDW2QJXT_0vsR0g4qMKygR_b4
(Rossana: Probably this comes from the literature where de novo' NAD synthesis is used to group the Asp and Trp.)
The text was updated successfully, but these errors were encountered: